The economics of health promotion and disease prevention: the way forward by Merkur, Sherry et al.
  
 Sherry Merkur,   David McDaid and Franco Sassi  
The economics of health promotion and 








Original citation: Originally published in: McDaid, David, Sassi, Franco and Merkur, Sherry, 
(eds.) Promoting Health, Preventing Disease: The Economic Case. UK higher education 
humanities & social sciences health & social welfare. Maidenhead, UK : Open University Press, 
2015, pp. 313-324.  
 
 
© 2015 World Health Organization 
 
This version available at: http://eprints.lse.ac.uk/62754/ 
Available in LSE Research Online: July 2016 
 
 
LSE has developed LSE Research Online so that users may access research output of the 
School. Copyright © and Moral Rights for the papers on this site are retained by the individual 
authors and/or other copyright owners. Users may download and/or print one copy of any 
article(s) in LSE Research Online to facilitate their private study or for non-commercial research. 
You may not engage in further distribution of the material or use it for any profit-making activities 
or any commercial gain. You may freely distribute the URL (http://eprints.lse.ac.uk) of the LSE 
Research Online website.  
 
This document is the author’s submitted version of the book section. There may be differences 
between this version and the published version.  You are advised to consult the publisher’s 
version if you wish to cite from it. 
 
 
At a time when public resources continue to be constrained, the role of 
economic evaluation in health promotion and disease prevention is an 
important consideration for policymakers to ensure that they are spending 
public money wisely. Helping people to achieve healthier lifestyles through 
effective policy action is imperative, particularly when markets fail. Market 
inefficiencies in these areas include, but are not limited to, externalities 
(when one’s health- related behaviours entail costs that are borne by others), 
and information challenges (when sound reliable information is limited or 
inaccessible). These inefficiencies mean that we cannot leave health promotion 
to markets alone.
Other research has shed light on behavioural failures which can be important 
in understanding people’s decision- making capabilities, the effects of influence, 
and inconsistencies in their preferences overtime. However, directly working 
to correct these types of failures may interfere with individual choice and be 
less acceptable to the public (see Chapter 1). Despite this, government 
intervention may be justified when health- related behaviours are addictive 
or habit- forming, and interventions may help to improve health and prevent 
disease.
This concluding chapter seeks to synthesize the evidence to make the economic 
case for investing upstream – that is, prior to the onset of noncommunicable 
diseases, and before health care services are required. It summarizes some of 
the most efficient health promotion and disease prevention policies for each of 
the major risk factors, discusses gaps in the evidence, highlights assumptions 
and potential limitations of the study, and presents trends in the use of cost- 
effective interventions. Finally, it looks at the economics of health promotion 
and disease prevention in the future, and proposes an agenda for future 
research.
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Summary of the evidence
This book has brought to light actions that can be supported by sound economic 
analyses to limit the risks produced by tobacco smoking, alcohol consumption, 
unhealthy diet, childhood exposure to environmental hazards and road- related 
injuries, and to promote physical activity and mental health. It has gone further 
to look at some of the social determinants of health by discussing the benefits 
of improved early childhood development and education. It also discussed the 
impact of these prevention programmes on health inequalities, the challenges 
of policy implementation, and the importance of intersectoral actions. The main 
messages of each chapter are captured in the evidence statements presented in 
the tables in the Policy Summary document online (Merkur et al. 2013: 48–72). 
Below, we have summarized some of the most important findings of the study 
by looking at important interventions and policy actions aimed at combating 
the major risk factors.
In the topic areas presented below, which focus on health- promoting 
interventions, it is necessary to recognize that we are not usually talking about 
interventions in isolation, but packages of actions – this can be seen most 
clearly in the smoking, alcohol, diet, and physical activity chapters, but applies 
more generally. The marginal benefits of expanded packages of actions often 
would still be considered cost- effective.
Tobacco smoking
The most cost- effective single tobacco control policy has been identified 
as raising taxes. The most cost- effective health care intervention to tackle 
smoking includes brief opportunistic advice from a general practitioner, along 
with telephone or self- help material. Pregnant women provide a particularly 
important group where low- cost smoking cessation interventions would be cost 
saving. An effective area towards raising awareness and changing attitudes, 
particularly in emerging economies, is the use of mass media campaigns, but 
these are often neglected. Other actions, such as labelling, smoking restrictions 
in public places and full advertising bans, often generate savings in health 
care expenditures which offset implementation costs. Importantly, the most 
effective means of reducing youth smoking is to reduce adult smoking via the 
mechanism of price increases, smoke- free policies, and of good, well- directed 
multimedia programmes.
Alcohol
Economic efficiency can be improved in the alcohol market when the negative 
externalities due to alcohol consumption can be reduced and where the socially 
optimum level of alcohol is sold and consumed in society. The three most cost- 
effective alcohol policies for reducing alcohol- related harm, and ones which 
correct some of alcohol’s market failures, are price increases, restrictions on 
availability, and bans on advertising. Impediments to implementing effective 
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policy in this area include failure to regulate the alcohol industry and to engage 
it in reducing harm in any meaningful way.
Physical inactivity
There is a strong economic case for investing in the promotion of physical 
activity. This is a leading contributor to good health, but more than one- third 
of Europeans are not sufficiently active. Mass media campaigns have been 
shown to have a positive, moderate effect on the increase of physical activity 
in targeted populations with a good cost- effectiveness ratio, and could even be 
cost saving. Brief primary care interventions to encourage physical activity, 
despite the higher cost, have been shown to be cost- effective. Some school- based 
interventions, particularly those that combine actions on physical activity and 
diet, seem to be more efficient than interventions on a single domain. Community- 
based interventions focussing on walking in particular (using pedometers) have 
been shown to be effective as well as cost- effective in the short term.
Unhealthy diets
When looking at policy actions to address unhealthy diets, taxes on foods 
high in salt, sugar, fat, and on junk food, are consistently cost saving and 
have a favourable health impact at the population level; both effectiveness 
and distributional impact of taxes appear to be enhanced by coupling them 
with subsidies targeting healthy foods or disadvantaged consumers. When 
designing interventions, one must be mindful of the challenge of product 
substitution when tax is used as an instrument, as consumers may switch to 
products that are also not healthy (as discussed later on). Policies aimed at the 
market environment for food choices, including making fruit and vegetables 
more available in schools, were found to have positive though modest effects 
on dietary intake and were cost- effective. Product reformulation policies (i.e. 
reducing salt in processed foods) were found to be cost saving or cost- effective, 
but the economic evidence on other efforts (e.g. to reduce trans- fat content) 
is very limited. The economic evidence on information campaigns is mixed, 
though food labelling schemes (especially mandatory ones) were found to 
perform better in terms of cost- effectiveness.
Environmental hazards for children
Because children are uniquely vulnerable to many common exposures in the 
environment, tackling environmental pollutants can help to protect children’s 
health. Abating mercury emissions by burning less or cleaner coal at power 
plants, or by capturing mercury during combustion, can reduce mercury 
hazards where the forecast health benefit is four times the cost. Similarly, lead 
decontamination in homes provides benefits in terms of avoided cost of illness. 
Positive health impacts have also been shown from reducing outdoor air pollution 
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from, for example, ozone and fine particulate matter, with efforts including 
congestion- charging schemes. In line with the objectives of the European 
Commission’s REACH (Regulation on Registration, Evaluation, Authorisation 
and Restriction of Chemicals) legislation, lots of damage can be avoided by 
shifting the burden of proof towards those proposing the introduction of a 
new, poorly understood chemical, and away from those analysing the negative 
health impacts of chemicals.
Road- related injuries
Cost- effective road safety policies have the potential to reduce injuries and 
deaths caused by road traffic accidents. Many interventions in this area are 
not only cost- effective, but likely to be cost saving from a societal perspective. 
These include road environmental modifications (i.e. traffic- calming measures, 
speed limit zones), police/technological enforcement of traffic regulations, 
investment in vehicle safety features and special targeted actions for high- risk 
drivers. This is also an area where there is substantial information available on 
the impact of legislative interventions. Furthermore, there is scope to work with 
industry to enhance safety standards of vehicles, and technological changes 
can be phased in over time.
Mental health
In an effort to protect mental health and prevent depression, there are cost- 
effective actions that are relatively simple, feasible and potentially scalable, 
across the life course and in different settings. For younger children at risk 
of developing conduct disorders, interventions targeting parents, parents 
and children – as well as those including parents – child- based training and 
teacher training, can be cost- effective, particularly when taking account of the 
well- document lifetime adverse impacts of poor mental health developing in 
childhood. Interventions to prevent depression in at- risk adolescents through 
after- school screening, and subsequent psychological intervention, would 
be cost- effective. New mothers at risk of post- natal depression (as identified 
by health visitors), coupled with subsequent therapy, appears cost- effective. 
Workplace interventions that can prevent depression and anxiety can be 
cost saving from a business perspective for white- collar employment; this 
area provides another example of the importance of working outside the 
governmental sector to promote health. There are potentially cost- effective 
actions for older people, from regular participation in group- based activities 
to tackle risks, to mental health and well- being that arise from isolation and 
loneliness, and stepped care approaches for older people at risk of depression 
(as identified in the primary care setting). Depression prevention in adults, 
which can be made accessible through self- help formats, that in some cases 
can be delivered through new technologies, reaching hard- to- reach populations 
such as young men, is potentially cost- effective, and may be cost saving when 
accounting for productivity losses averted.
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Social determinants
When working to improve the social determinants of health, the economic 
returns from investing in early childhood development intervention programmes 
are larger when the programmes follow a more targeted approach (e.g. high- 
risk or disadvantaged populations), involve children as participants, focus on 
enhancing parenting efficacy, and have better trained staff. But both targeted 
and universally delivered early childhood development interventions can 
demonstrate good value for money, despite the likelihood of underestimation 
of benefits due to the omission of health benefits in many cost- benefit 
calculations. The economic evidence for the financial returns from investments 
in education is well- established, and the added value of the health benefits of 
education further strengthens the overall case. The economic case for investing 
in early years interventions has been strengthened by evidence from numerous 
birth cohort studies that there are long- term consequences of adverse health in 
childhood – not just poor health, but poor educational outcomes, employment 
and career prospects, difficulties in personal relationships, and more risk of 
contact with criminal justice systems. This is an example of how long- term 
monitoring systems can help inform the evidence base for health promotion 
and disease prevention.
Measurement considerations
There are some key considerations for policymakers and others when 
considering and interpreting the evidence provided by economic evaluations 
in health promotion and disease prevention. First, to account for the way that 
intervention outcomes are measured – in natural units, utilities or monetary 
values, depending on the type of economic evaluation technique used. Utility 
measures like quality- adjusted life- years (QALYs) and disability- adjusted life- 
years (DALYs) are the most commonly used generic outcome measures.
There are also challenges in the way in which evidence of effectiveness can 
be determined. For many complex interventions it may be difficult to conduct 
randomized controlled trials, and other forms of study design have to be used. 
They may have greater risks of bias in their internal validity, but may be more 
helpful in terms of external validity, especially where issues such as cultural 
sensitivity and appropriateness are considered – the cost- effectiveness of 
interventions for health promotion and disease prevention will often be heavily 
influenced by rates of uptake and continued participation. Modelling studies, 
which synthesize costs and benefits from a number of studies, are also widely 
used. They can be helpful in assessing the potential long- term economic benefits 
of investment, and can also be adjusted to take account of uncertainty – for 
instance, in respect of levels of effectiveness and uptake rates. These types of 
studies can also be used to model the long time horizons by using intermediate 
outcomes, e.g. stopping smoking or changing a risky behaviour. Taking a long- 
term perspective is necessary in many cases because, with interventions, the 
largest health gain is to be expected when a healthy lifestyle is adapted early on 
(possibly in childhood) and maintained throughout adulthood.
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Moreover, it is useful to consider differences in the cost- effectiveness 
and equity implications of interventions between several population sub- 
groups, because public health interventions have a high potential to reduce 
socioeconomic health inequalities, but can in some circumstances widen health 
inequalities depending on which population groups actually make use of an 
intervention.
Specific gaps in the evidence
The evidence presented in this book has relied on published articles and 
larger studies; where systematic reviews have been undertaken on a policy or 
intervention, these have been presented. Gaps in the evidence remain, and the 
evidence on many interventions is equivocal.
This book has focused on interventions for the prevention of chronic 
noncommunicable diseases (NCDs), and certain types of injuries. Less attention 
has been devoted to prevention efforts within the health care system, such as 
screening programmes or pharmacological prevention, and this book has not 
covered the prevention of infectious diseases. There are systematic reviews 
of evidence and studies on the cost- effectiveness of screening procedures, 
vaccinations and other interventions available from the National Institute of 
Health and Care Excellence and the Centers for Disease Control and Prevention.
There is also potential for using behavioural science to design interventions 
that could be more acceptable to users and/or may steer them to make a choice 
to engage in health promoting behaviour. There is emerging evidence on the 
potential of ‘nudging’ interventions, although this area is still in its infancy. 
Hollands et al. (2013) argue that the limitations of the evidence base for altering 
environments to induce behavioural change – so- called choice architecture – 
goes beyond a lack of evidence to an absence of definitions and concepts of 
what this actually means to public health interventions. The Behavioural Insights 
Team in England, which has worked on applying behavioural science principles 
to government policy, has promoted a Parliamentary Select Committee review 
to find that ‘non- regulatory measures used in isolation, including “nudges”, are 
less likely to be effective. Effective policies often use a range of interventions.’ 
(UK Select Committee 2011). They also cautioned that the preference of 
government for non- regulatory interventions has prompted officials to ‘exclude 
consideration of regulatory measures when thinking about behaviour change’ 
(UK Select Committee 2011).
With regards to gaps in the evidence, in the literature on alcohol there remains 
insufficient evidence on the effectiveness of school- based interventions and 
mass media campaigns. There is a gap in the physical activity literature around 
community- based interventions with regards to walking. Future research 
could study the potential cost- effectiveness around walking groups and remote 
mediated interventions. Also, for children, mixed evidence remains on the 
cost- effectiveness of walking buses. Another area where the cost- effectiveness 
evidence is inconsistent is related to road traffic accidents, specifically 
national compulsory bicycle helmet laws. More studies could be undertaken 
in this area, as from a public sector perspective (where the private cost of 
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purchasing helmets is omitted) the measure is likely to be highly cost- effective. 
Nevertheless, when considering cycling from a physical activity perspective, 
there is good evidence that a comprehensive set of infrastructures can lead to 
increases in cycling in a population.
Crucial gaps are also still present in the cost- effectiveness of potential policy 
options for combating unhealthy diets. Future research in this area could 
aim to examine the architecture of food choices and restricting junk food in 
schools. Effectiveness evidence needs to be gathered on supply- side changes 
triggered by government regulation and policies, as well as on agricultural and 
food- chain incentives. Another important area for research could examine the 
broader effects of interventions on people’s overall preferences and dietary 
habits, rather than specific foods or nutrients.
Serious gaps remain in the children’s environmental- health literature. Towards 
reducing outdoor air pollution, schemes for low- emission zone requirements 
need to be assessed for potential health and economic benefits. Future research 
could focus on combating the large uncertainties that remain in estimating the 
effects of environmental health hazards and improving our understanding of 
the long- term health impacts of early- life exposure to chemicals. Furthermore, 
additional coordination of assessments of children’s environmental health risks, 
beyond traditional chemicals risks, is necessary for advancing global policy in 
this area.
Future work will also need to consider the lack of evidence on social 
determinants and the poor evidence of equity. New technologies may offer some 
potential to test the evidence on effectiveness and equity. For example, work on 
virtual (but real) supermarkets using computer software is being used to study 
food choice in a randomized controlled trial in New Zealand.
There is a high concentration of evidence in a small number of countries, as 
seen in the evidence tables (these can be found in the Policy Summary document 
available online: Merkur et al. 2013: 48–72). This presents challenges when 
considering the appropriateness of actions in different countries or settings. 
For instance, there is very little evidence from most countries in the east of 
the European Region. This may have many causes, including capacity issues, 
issues of priority, publication of early work in languages that are inaccessible 
to researchers abroad, etc.
Study assumptions and limitations
In order to conduct rigorous economic evaluations, good evidence must be 
available. Some economic evaluations make up for gaps in the effectiveness 
evidence by making assumptions and extrapolations. The specific 
methodological assumptions and techniques involved in cost- effectiveness 
analyses can have significant implications. The main assumptions include 
the value of health and life, the appropriate discount rate, the selected end 
point, as well as taking the economic perspective rather than other ethical 
considerations, such as fairness and distributive justice. Even where evidence is 
available, it can suffer from a lack of generalizability and reliance on relatively 
weak investigation approaches.
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One of the key challenges for effectively utilizing economic evaluation to 
assess public health interventions is the length of the causal chain between 
interventions and outcomes. Rather than wait for the long time horizon to pass 
between intervention and health outcome, researchers have to use intermediate 
outcomes or risk factors – which have a shorter time horizon – to calculate 
expected outcomes or long- term effects using a modelling approach. The 
challenges with modelling are that many assumptions have to be made, including 
about the long- term effects of a policy. For example, when considering a school- 
based intervention it is necessary to make an assumption about what percentage 
of children will retain in the long term the health- related information that is 
taught (i.e. to not smoke) or the behavioural change that is introduced (i.e. to eat 
more fruit and vegetables). Although some studies use intermediate outcomes, 
the key challenge remains to effectively map clinical disease pathways to 
improve the validity of modelling approaches in all relevant areas for public 
health intervention.
Next, it is difficult to predict what individuals will consume as substitutes, e.g. 
for a fat tax on soft drinks, individuals may consume another beverage that falls 
outside the tax, but has a comparable amount of sugar. Another example of sub-
stitution is the German alcopop tax, which simply switched consumption of spirits- 
based mixed beverages to beer- based mixed beverages. Since individuals make 
substitutions that may cause interventions to have unintended consequences, 
policies must be designed carefully to avoid undesirable substitution effects. 
Moreover, the food industry, for instance, is continuously innovating, creating 
new complex foods that may serve as substitutes in the future; the alcohol and 
tobacco industries continue to make substitution products as well, thus rele- 
vant regulations may need to increase in scope to catch these new substitutes.
There are many challenges to communicating health- promotion messages 
effectively. For instance, vested interests have actively worked against research 
findings that damage their particular interests. In Chapter 13, examples are 
provided for the tobacco industry, asbestos industry and others about how 
commercial interests can use weak but well- resourced arguments to challenge 
good evidence regarding health promotion. Therefore, it is important to 
effectively communicate the evidence to counter this – for example, by providing 
information using language that is accessible and easily understood by the public.
For some policy actions which have been shown to have positive economic 
gains, and for which there is already legislation implemented in most European 
countries – for example, motorcycle helmet legislation – the behaviour may 
continue to vary due to cultural norms. Furthermore, to combat mental health 
problems in the target group of new mothers, a preventative intervention for 
women at high risk of developing post- partum depression would require an 
understanding and recognition of early risk factors, along with the availability 
of relevant health professionals to reach this group. These examples show 
that, even where there is a strong case for careful investment in action, any 
intervention needs to be sensitive to local conditions, culture, infrastructure 
and resources. The importance of context in any evaluation, whether analysing 
effectiveness or cost- effectiveness, must not be overlooked.
In particular, when examining programmes to tackle the social determinant of 
health, it is difficult to compare results across interventions. This has to do with 
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the intensity of interventions, different ages of participants in early childhood 
interventions, and given the large differences in costs and saving components 
included in the estimations. Also, when analysing early childhood development 
interventions from a health perspective, economic evaluations have scarcely 
taken account of the health benefits; thus the full return on investment may 
actually be higher than what is suggested by current studies.
In areas where there is a scarcity of evaluative and economic evidence 
generated in low- and middle- income countries (for example on road safety), this 
raises challenges in the potential transferability of cost- effective interventions 
across the European region. There are also areas where the majority of 
evidence comes from other regions. For example, there is a strong American 
bias on the evaluation of early childhood development interventions, as well as 
a scarcity of European evidence on the long- term effects of these programmes. 
Furthermore, more evidence is needed on cost- effective interventions in low- 
and middle- income countries.
Even when the above obstacles are understood and potentially overcome, 
simply identifying that there is an economic case for action, or even to identify 
cost- effective interventions, is just the start. The implementation of actions faces 
many challenges. Cross- sectoral working is vital, as many of the costs – as well 
as some benefits – fall outside the health sector and under the responsibility 
of other government ministers, i.e. education, environment, finance, transport 
and even agriculture. In areas where effective policies will need to combine a 
range of actions at different levels, e.g. in tackling tobacco smoking, alcohol 
consumption or improving road safety, there remains a need to further develop 
methods to estimate the effectiveness and cost- effectiveness of different 
packages of interventions that could be included in a national policy involving 
other government ministries beyond the health minister.
Trends in cost- effective interventions
Most countries are putting efforts into improving health education and 
information. However, the evidence in this book has suggested that these 
measures alone are not sufficient, nor are they always cost- effective. More 
stringent measures, such as regulation of advertising or fiscal measures, are 
more intrusive on individual choices and more likely to generate conflict among 
relevant stakeholders, but are also likely to weigh less on public finances and to 
produce health returns more promptly.
Fiscal measures, such as taxation, are effective for increasing the prices 
of tobacco and alcohol towards reducing consumption. Advertising bans are 
also effective at reducing consumption levels, but these must be full bans. 
Nevertheless, fiscal measures are complex to design and enforce; their impact 
may be unpredictable; and they can bear more heavily on low- income groups than 
on those with higher incomes. Despite this latter point though, it can be argued 
that the low- income groups stand to gain the most from these interventions in 
terms of increased health outcomes. For example, food taxes are likely to be 
regressive, although the less well off also benefit disproportionately from their 
effects.
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Having different government ministries working together with the ministry 
of health is an important consideration, as many of the interventions discussed 
in the book are often delivered outside the health care system, using resources 
from different areas of government spending. Although there may be discussion 
in various levels of government on the importance of health in all policies, 
there may be little in the way of institutional structures and communication 
mechanisms to encourage action. Chapter 14 provides a long list of barriers 
to the cross- sectoral implementation of health- promotion measures. However, 
some methods have been proposed to promote intersectoral work, including 
presenting the economic benefits to non- health sectors of investing in health- 
promoting interventions; tearing down silos between budgets, with different 
forms of shared financing on either a voluntary or mandatory basis; and 
bringing budgets together can help embed health impacts in all policies. These 
methods require trust, and approaches need to be tailored to account for 
different political climates and cultures, infrastructure and resources.
The economics of health promotion in the future
The ideas and evidence explored in this book provide a valuable starting point 
for action, but also bring forward a research agenda for the future. Ongoing 
work in the areas already discussed will allow policymakers to consider a 
broader range of actions in the future. By undertaking research in the areas 
listed below, decision- makers will gain greater insights and better knowledge 
for the full range of outcomes those interventions may produce.
Areas for future work in the various areas include:
• Creating consistent monitoring systems of epidemiological data will help to 
understand differences in disease burden between countries.
• Monitoring different policy efforts in risk factor areas between countries 
could help researchers explain some of the differences in lifestyle factors.
• Undertaking research into national policies which include the important 
elements of multiple, coherent, long- lasting and large- scale strategies.
• Bettering our understanding of how to facilitate closer cooperation between 
all the relevant actors in different government ministries.
• Improving methods of engagement and voluntary participation by industry 
towards health- promoting efforts particularly related to tobacco, alcohol 
and food.
• For mental health, collecting evidence on different workplace settings – for 
example, where staff turnover is high and skill requirements low – would 
help strengthen the case for companies to invest. Also, improving our 
understanding of the links between mental and physical health to make a 
more holistic argument for prevention.
• Expanding research on early childhood development to other parts of the 
European Region. Previously, much of the evidence had come from the 
United States, but there are now many European studies underway to assess 
a variety of interventions in a European context, especially in the United 
Kingdom, the Netherlands and the Nordic countries.
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• Understanding the long- term benefits of better psychological well- being, and 
understanding whether better well- being is actually going to be a protective 
factor for health at a future point in time.
Reducing the risk of chronic diseases and injury through interventions aimed 
at modifying lifestyle risk factors is possible and cost- effective, and potentially 
could reduce health inequalities within countries. However, turning the tide of 
chronic health problems that have assumed epidemic proportions during the 
course of the twentieth century requires fundamental changes in the social 
norms that regulate individual and collective behaviours. Such changes can 
only be triggered by wide- ranging prevention strategies addressing multiple 
determinants of health across social groups. The challenge now is to look at 
ways in which the evidence may be used to translate evidence- based knowledge 
into routine everyday practice across all of the WHO European Region.
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